Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B immunization programme: lessons learnt in Greece

G Papaevangelou1

  • 1Faculty of Nursing, University of Athens, Greece.

Vaccine
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decline of hepatitis B infection in Greece.

European journal of epidemiology·1999
Same author

Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

European journal of epidemiology·1999
Same author

Hepatitis B maternal-fetal transmission in Southern Europe.

Intervirology·1999
Same author

Current combined vaccines with hepatitis B.

Vaccine·1999
Same author

Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.

Vaccine·1997
Same author

Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule.

Vaccine·1995
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
See all related articles

Greece implemented a national hepatitis B prevention program in 1998, including universal infant and adolescent immunization. This initiative aims to reduce the high hepatitis B virus (HBV) burden in the European Union.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Greece historically faced the highest hepatitis B virus (HBV) burden within the European Union.
  • Heterosexual contact was the primary transmission route, particularly affecting adult males (30%) and women of reproductive age (50%).
  • An earlier prevention program targeting high-risk groups (initiated 1982) showed limited impact on disease incidence and prevalence.

Purpose of the Study:

  • To detail the implementation and components of Greece's national hepatitis B prevention program.
  • To outline the strategic shift from a targeted to a universal immunization approach.
  • To address the persistent public health challenge of hepatitis B in Greece.

Main Methods:

  • The national program, effective from early 1998, integrated universal infant and adolescent immunization.

Related Experiment Videos

  • Screening of pregnant women was included as a key component.
  • Continued immunization of high-risk groups was maintained alongside universal strategies.

    • Main Results:

    • The abstract does not contain specific results data.
    • The program's implementation signifies a comprehensive public health strategy shift.
    • Focus on universal vaccination and screening aims to control HBV transmission.

    Conclusions:

    • The national hepatitis B prevention program represents a significant public health intervention in Greece.
    • Universal immunization and targeted screening are key strategies to combat HBV.
    • The program's success will be measured by its impact on HBV incidence and prevalence.